These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29683361)

  • 1. Human recombinant epidermal growth factor in skin lesions: 77 cases in EPItelizando project.
    Esquirol-Caussa J; Herrero-Vila E
    J Dermatolog Treat; 2019 Feb; 30(1):96-101. PubMed ID: 29683361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epidermal growth factor in diabetic rats.
    Chu Y; Yu D; Wang P; Xu J; Li D; Ding M
    Wound Repair Regen; 2010; 18(5):499-505. PubMed ID: 20840519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidermal growth factor, innovation and safety].
    Esquirol Caussa J; Herrero Vila E
    Med Clin (Barc); 2015 Oct; 145(7):305-12. PubMed ID: 25433777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: a randomized double-blinded controlled trial.
    Gomez-Villa R; Aguilar-Rebolledo F; Lozano-Platonoff A; Teran-Soto JM; Fabian-Victoriano MR; Kresch-Tronik NS; Garrido-Espíndola X; Garcia-Solis A; Bondani-Guasti A; Bierzwinsky-Sneider G; Contreras-Ruiz J
    Wound Repair Regen; 2014; 22(4):497-503. PubMed ID: 25041620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
    Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Human Recombinant Epidermal Growth Factors vs Conventional Therapy for the Treatment of Chronic Venous Ulcers: A Retrospective Case Series.
    Cacua Sanchez MT; Giraldo LF; Díaz JA
    Wounds; 2021 Feb; 33(2):41-49. PubMed ID: 33591927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of recombinant human epidermal growth factor on chronic ulcer wound].
    Zhu JX; Zhang YM
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):42-3. PubMed ID: 11826651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of epidermal growth factor and basic fibroblast growth factor on wound healing].
    Fu XB; Sun TZ; Wang YP
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 1999 Sep; 13(5):278-82. PubMed ID: 12080818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients.
    Shin JU; Kang SW; Jeong JJ; Nam KH; Chung WY; Lee JH
    J Dermatolog Treat; 2015 Apr; 26(2):159-64. PubMed ID: 24708156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study on burn wound healing treated by different methods of recombinant human epidermal growth factor].
    Liao Y; Guo L; Ding EY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 Jul; 17(4):301-2. PubMed ID: 12920719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acceleration of burn wound healing with topical application of recombinant human epidermal growth factor ointments].
    Wang SL; Ma JL; Chai JK
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 May; 16(3):173-6. PubMed ID: 12569689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Topical Recombinant Human Epidermal Growth Factor for Treatment of Diabetic Foot Ulcer: A Systematic Review and Meta-Analysis.
    Yang S; Geng Z; Ma K; Sun X; Fu X
    Int J Low Extrem Wounds; 2016 Jun; 15(2):120-5. PubMed ID: 27151755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dextrin-rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse.
    Hardwicke JT; Hart J; Bell A; Duncan R; Thomas DW; Moseley R
    J Control Release; 2011 Jun; 152(3):411-7. PubMed ID: 21435363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice.
    Gainza G; Pastor M; Aguirre JJ; Villullas S; Pedraz JL; Hernandez RM; Igartua M
    J Control Release; 2014 Jul; 185():51-61. PubMed ID: 24794895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of topical external administration of recombinant human epidermal growth factor on expression of epidermal growth factor receptor and its mRNA in scald wound of diabetes mellitus rat].
    Zong S; Liang Z; Ou B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Feb; 24(2):150-5. PubMed ID: 20187444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
    Santana H; García G; Vega M; Beldarraín A; Páez R
    PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds.
    Hardwicke J; Moseley R; Stephens P; Harding K; Duncan R; Thomas DW
    Mol Pharm; 2010 Jun; 7(3):699-707. PubMed ID: 20166755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of hydrogel embedded polymer-growth factor conjugated nanoparticles as a diabetic wound dressing.
    Hajimiri M; Shahverdi S; Esfandiari MA; Larijani B; Atyabi F; Rajabiani A; Dehpour AR; Amini M; Dinarvand R
    Drug Dev Ind Pharm; 2016 May; 42(5):707-719. PubMed ID: 26266962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal Growth Factor is Effective in the Treatment of Diabetic Foot Ulcers: Meta-Analysis and Systematic Review.
    Bui TQ; Bui QVP; Németh D; Hegyi P; Szakács Z; Rumbus Z; Tóth B; Emri G; Párniczky A; Sarlós P; Varga O
    Int J Environ Res Public Health; 2019 Jul; 16(14):. PubMed ID: 31331038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of intralesional recombinant human epidermal growth factor in chronic diabetic foot ulcers.
    Dumantepe M; Fazliogullari O; Seren M; Uyar I; Basar F
    Growth Factors; 2015 Apr; 33(2):128-32. PubMed ID: 25856197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.